William Desmarais - Net Worth and Insider Trading
William Desmarais Net Worth
The estimated net worth of William Desmarais is at least $13,800 dollars as of 2024-09-20. William Desmarais is the Chief Business Officer of TScan Therapeutics Inc and owns about 2,500 shares of TScan Therapeutics Inc (TCRX) stock worth over $13,800. Details can be seen in William Desmarais's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Desmarais has not made any transactions after 2021-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Desmarais
William Desmarais Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Desmarais owns 1 companies in total, including TScan Therapeutics Inc (TCRX) .
Click here to see the complete history of William Desmarais’s form 4 insider trades.
Insider Ownership Summary of William Desmarais
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2021-08-27 | Chief Business Officer |
William Desmarais Latest Holdings Summary
William Desmarais currently owns a total of 1 stock. William Desmarais owns 2,500 shares of TScan Therapeutics Inc (TCRX) as of August 27, 2021, with a value of $13,800.
Latest Holdings of William Desmarais
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2021-08-27 | 2,500 | 5.52 | 13,800 |
Holding Weightings of William Desmarais
William Desmarais Form 4 Trading Tracker
According to the SEC Form 4 filings, William Desmarais has made a total of 1 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 2,500 shares on August 27, 2021, which cost William Desmarais around $22,700.
Insider Trading History of William Desmarais
- 1
William Desmarais Trading Performance
GuruFocus tracks the stock performance after each of William Desmarais's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Desmarais is -1.8%. GuruFocus also compares William Desmarais's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Desmarais within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Desmarais's insider trading performs compared to the benchmark.
Performance of William Desmarais
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.98 | | | | | |
| Relative Return to S&P 500(%) | -7.51 | | | | | |
William Desmarais Ownership Network
William Desmarais Owned Company Details
What does TScan Therapeutics Inc do?
Who are the key executives at TScan Therapeutics Inc?
William Desmarais is the Chief Business Officer of TScan Therapeutics Inc. Other key executives at TScan Therapeutics Inc include Chief Legal Officer Zoran Zdraveski , Chief Accounting Officer Leiden Dworak , and 10 percent owner Weston Nichols .
TScan Therapeutics Inc (TCRX) Insider Trades Summary
Over the past 18 months, William Desmarais made no insider transaction in TScan Therapeutics Inc (TCRX). Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 67,027 shares made by Timothy J Barberich , a net purchase of 15,000 shares made by Barbara Klencke , and a net sale of 164,686 shares made by Zoran Zdraveski .
In summary, during the past 3 months, insiders sold 164,686 shares of TScan Therapeutics Inc (TCRX) in total and bought 10,000 shares, with a net sale of 154,686 shares. During the past 18 months, 190,086 shares of TScan Therapeutics Inc (TCRX) were sold and 82,027 shares were bought by its insiders, resulting in a net sale of 108,059 shares.
TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TScan Therapeutics Inc Insider Transactions
William Desmarais Mailing Address
Above is the net worth, insider trading, and ownership report for William Desmarais. You might contact William Desmarais via mailing address: C/o Tscan Therapeutics, Inc., 830 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
